Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Topical corticosteroids are effective for skin conditions but can have side effects.

A new method accurately measures clobetasol propionate in hair and skin.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

AFL is safe and effective for topical drug delivery but needs larger studies and cheaper devices for wider use.

Combining pentoxifylline with corticosteroids improves alopecia areata treatment.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

LC-OCT is a useful noninvasive tool for diagnosing and monitoring alopecia areata.

Baricitinib is effective as a treatment for severe hair loss.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.